When my brother Sam finally asked his GP for help with his weight, he expected a leaflet. He had a BMI of 37, a blood pressure of 152 over 96, prediabetes, and twenty years of trying and failing on his own behind him. What he got instead was a proper conversation about obesity treatment as a medical condition: what a structured programme could realistically do, what the new injectable medicines could do, what surgery could do, and what each of them could not. He told me afterwards that the thing that undid him was the doctor saying, "This is not a character problem. It is a biology problem, and we have treatments for biology."
That sentence is the frame for this article. Can obesity be cured? What does treatment for obesity actually involve in 2026, from lifestyle programmes to very low calorie diets to semaglutide, tirzepatide, the new pills and bariatric surgery? How much weight does each produce, what are the risks, what happens when you stop, and how do you choose? The numbers come from the trials, and I have tried to be as honest about the disappointments as about the breakthroughs, because there have been plenty of both.
Can obesity be cured? The honest answer
Obesity can be treated very effectively. Whether it can be cured, in the sense of going away and staying away without ongoing effort, is a harder question, and the science says that for most people the answer is no, in the same way that high blood pressure is controlled rather than cured. The reason is that the body defends its highest weight. After significant weight loss, hunger hormones rise, fullness hormones fall and resting metabolism drops further than the loss of tissue would predict, and these changes persist for years. The starkest demonstration came from following contestants on the American television programme The Biggest Loser: six years after losing an average of 58 kg, most had regained most of it, and their resting metabolism was still around 500 calories a day lower than expected for their size (Fothergill et al., Obesity, 2016).
This is why every major guideline now describes obesity as a chronic, relapsing condition needing long term management, and why the most effective treatments are the ones that alter the biology of appetite rather than simply asking people to resist it. It is also why "cure" is the wrong goal. The right goal is a weight at which your health risks fall substantially and which you can sustain with a level of effort you can live with. That turns out to be achievable for far more people than it was ten years ago.
How much weight loss is enough?
Less than most people think. The benefits of weight loss follow a dose response:
- 3 to 5 percent: measurable improvements in blood sugar, triglycerides and blood pressure.
- 5 to 10 percent: 58 percent reduction in progression to type 2 diabetes in people with prediabetes (Diabetes Prevention Program), improved sleep apnoea, fatty liver and joint pain, and in the Look AHEAD trial, significant reductions in medication use and improved mobility (Look AHEAD Research Group, NEJM, 2013).
- 10 to 15 percent: remission of type 2 diabetes in around half of people diagnosed within six years (DiRECT trial), resolution of sleep apnoea in many, large reductions in heart failure symptoms.
- 15 percent and above: the range where the new medicines and surgery operate, with reductions in heart attacks, strokes and death.
Knowing your starting point helps you set the target. Our BMI calculator shows how far a 5, 10 or 15 percent loss would move you, and applies the lower thresholds that matter for people of South Asian, Chinese and Black heritage, who reach the same metabolic risk at a BMI of 23 as others do at 25 and are eligible for treatment at correspondingly lower BMIs.
The treatment ladder, compared
1. Structured lifestyle programmes: 5 to 8 percent
A programme with regular contact, a calorie target, a physical activity goal and behavioural support produces an average loss of 5 to 8 percent at one year, with roughly half of that maintained at four years in Look AHEAD. It is the foundation of every other treatment, not an alternative to them. Commercial programmes such as WeightWatchers perform similarly to NHS and clinical programmes in head to head trials. The details of what to eat and how to move are in our obesity diet and exercise plan.
2. Very low calorie diets and total diet replacement: 10 to 15 percent, fast
In the DiRECT trial, people with type 2 diabetes replaced all meals with 850 calorie a day shakes and soups for 12 to 20 weeks, then reintroduced food with support. At one year they had lost an average of 10 kg and 46 percent were in diabetes remission, rising to 86 percent among those who lost 15 kg or more (Lean et al., Lancet, 2018). The NHS now offers this programme. The catch is regain: at five years, about a third of the weight had returned on average, and remission fell accordingly. It works best as a launch, with something sustainable planned for afterwards. Rapid weight loss also raises the risk of gallstones, which is worth knowing before you start.
3. Medicines: the change of the decade
For decades obesity drugs were weak, risky or both. Orlistat, which blocks fat absorption, produces about 3 percent extra loss and unpleasant side effects. Then in 2021 a diabetes drug class, the GLP-1 receptor agonists, changed everything.
Semaglutide 2.4 mg (Wegovy). A weekly injection that mimics a gut hormone, slowing stomach emptying and, more importantly, quietening the appetite centres in the brain. In the STEP 1 trial, adults with obesity lost an average of 14.9 percent of body weight over 68 weeks against 2.4 percent on placebo, and a third lost more than 20 percent (Wilding et al., NEJM, 2021). Sam describes it as "the food noise stopping": for the first time in his adult life he could leave half a plate.
Tirzepatide (Mounjaro in the UK, Zepbound in the US). Acts on two gut hormone receptors, GLP-1 and GIP. In SURMOUNT-1, the highest dose produced an average loss of 20.9 percent over 72 weeks, with more than half of participants losing at least 20 percent, results that approach bariatric surgery (Jastreboff et al., NEJM, 2022). In a head to head trial published in 2025 it outperformed semaglutide.
Oral options. Higher dose oral semaglutide and the new once daily pill orforglipron, which produced around 12 percent weight loss at 72 weeks in its phase 3 trial (Jastreboff et al., NEJM, 2025), are arriving through 2026 and should widen access and lower cost.
Do they improve health, or just the number? Both. In the SELECT trial of 17,604 people with obesity and existing heart disease, semaglutide reduced heart attacks, strokes and cardiovascular deaths by 20 percent over three years (Lincoff et al., NEJM, 2023). Trials have since shown benefits for kidney disease, heart failure, sleep apnoea and fatty liver.
The downsides, plainly. Nausea, constipation, diarrhoea and reflux are common in the first months and usually settle. Gallstones are more frequent, as with any rapid weight loss. Pancreatitis is rare but real. Around a quarter to a third of the weight lost is lean tissue, so resistance exercise and adequate protein are not optional. They are expensive and often not funded. And the biggest issue is what happens when they stop.
When participants stopped semaglutide after 68 weeks, they regained an average of two thirds of the lost weight within a year, and their blood pressure and cholesterol drifted back with it (Wilding et al., Diabetes, Obesity and Metabolism, 2022). That is exactly what happens when you stop a blood pressure tablet, and it is why these are long term treatments. Some people do successfully step down to a lower dose or stop after building strong habits; most need to continue in some form. Anyone starting should plan for that from day one.
4. Bariatric surgery: 25 to 30 percent, durable
Sleeve gastrectomy and gastric bypass remain the most effective and durable treatments. In a 12 year follow up, gastric bypass patients maintained an average loss of 27 percent of body weight, with type 2 diabetes in remission in half of those who had it and large reductions in new diagnoses (Adams et al., NEJM, 2017). The Swedish Obese Subjects study found surgery reduced overall mortality by about 30 percent over 20 years. Surgery works partly by restricting intake but mostly by changing the same gut hormones the medicines target, which is why appetite falls rather than simply being frustrated. Risks include surgical complications in around 5 percent, nutritional deficiencies requiring lifelong supplements, and in some people, alcohol problems or regain. It is offered at a BMI of 40, or 35 with complications, and at 30 for people of South Asian heritage with type 2 diabetes in UK guidance.
Choosing: a rough guide
| Situation | Reasonable first steps |
|---|---|
| BMI 25 to 30 (23 to 27.5 in higher risk ethnic groups), no complications | Structured lifestyle change, weekly weighing, sleep and ultra processed food as priorities |
| BMI 30 to 35, or 27 with prediabetes, high blood pressure or sleep apnoea | Lifestyle programme plus discussion of GLP-1 medicines; total diet replacement if diabetes is recent |
| BMI 35 to 40 with complications | Medicines as standard; surgical referral is a legitimate option to raise |
| BMI over 40, or over 35 with type 2 diabetes | Surgery has the strongest long term evidence; medicines are a reasonable alternative or bridge |
| Any BMI with weight gaining medicines | Review those first; the gain often reverses |
What about "natural" cures?
Apple cider vinegar, green tea extract, garcinia, raspberry ketones, berberine and the rest have been tested, and the best of them produce a kilogram or so more than placebo over months. None comes close to the treatments above, and some supplements sold for weight loss have contained undeclared prescription drugs. Intermittent fasting works about as well as ordinary calorie restriction, no better and no worse, in head to head trials, so if you prefer it, use it. Keto works for those who like it and stall for those who do not. There is no secret; there is what you can sustain, plus, for many people, medical help with the biology.
Where Sam is now
He chose the injections, alongside the programme his GP practice ran and a decision to lift weights twice a week so he would not lose muscle. Eighteen months on he has lost 22 kilograms, his blood pressure is normal on no tablets, his HbA1c is out of the prediabetic range, and he is on a lower maintenance dose with a plan to try stepping down further next year. He is clear eyed about the possibility that he may need it long term, and clear eyed too that he would take a blood pressure tablet for life without a second thought. What has changed most, he says, is the shame. Understanding that his weight was defended by his biology, and treatable by medicine, did more for his mental health than the weight loss did. If you are at the start of that road, the causes and prevention article explains the biology in full, and the diet and exercise plan is what to do on the ground, whichever treatment you choose.
Read next
- How to prevent obesity: causes, risk factors and what actually works
- Obesity diet and exercise plan: what to eat and how to move when you have a lot to lose
- BMI calculator with Asian and Black thresholds
- How to prevent gallstones: why fast weight loss raises the risk
Frequently asked questions
Can obesity be cured permanently?
Obesity is best thought of as a chronic condition that can be controlled very effectively rather than cured. After weight loss the body raises hunger and lowers metabolism to defend its previous weight, which is why long term support, and for many people long term medication, produces the best results.
What is the most effective treatment for obesity?
Bariatric surgery produces the largest and most durable weight loss, around 25 to 30 percent maintained for over a decade. Tirzepatide and semaglutide produce 15 to 21 percent on average while taken. Structured lifestyle programmes produce 5 to 8 percent and underpin every other treatment.
Do you regain weight after stopping Wegovy or Mounjaro?
Most people regain a substantial proportion, around two thirds within a year in the STEP 1 extension study. This reflects the underlying biology of obesity rather than a failure of the drug, and is why these medicines are generally used long term, sometimes at reduced doses.
How much weight do I need to lose to improve my health?
Five percent produces measurable benefits; 5 to 10 percent cuts diabetes risk by more than half and improves blood pressure, sleep apnoea and fatty liver; 10 to 15 percent can put recent type 2 diabetes into remission.
This article is for general information and does not replace advice from your own doctor. Weight loss medicines and surgery have specific eligibility criteria, risks and monitoring requirements that need individual assessment.
